HR

Hiten Rasiklal Shah

Director Director DIN 01435883
DIN 01435883 First appointment Oct 1994 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 2 historical roles
Total affiliations 2 Since Oct 1994
Shareholding value β€’β€’β€’β€’ Premium profile

About Hiten Rasiklal Shah

Data last updated:

Hiten Rasiklal Shah has 32 years in corporate governance. Formerly with 2 companies, such as Aan Pharma Pvt Ltd and Evolet Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01435883
Primary Designation Director
First Appointment 07 Oct 1994
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aan Pharma Pvt Ltd U24231GJ1994PTC023223
Director07 Oct 19941994₹4.40 Cr (FY 2025)Active
Director06 Apr 20052005₹35.41 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aan Pharma Pvt Ltd
Evolet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Hiten Rasiklal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hiten Rasiklal Shah

Hiten Rasiklal Shah has 32 years in corporate governance. Formerly with 2 companies, such as Aan Pharma Pvt Ltd and Evolet Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Hiten Rasiklal Shah has expertise in General Business.

Hiten Rasiklal Shah has 32 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available